2Van den Berghe G, WoutersP, Wekers F, et al. Intensive insulin therapy in critically ill patients [J]. N Eng J Med, 2001, 345(19): 1359.
3The NICE- SUGAR Study Investigators. Intensive versus Conventional Glucose Control in Critically III Patients[J]. N Engl J Med, 2009, 360(13) : 1283.
4Moghissi E S, Korytkowski M T, DiNardo M. American Association of Clinical Endocrinologists and American Dia- betes Association consensus statement on inpatient glycemic control[J]. Endocr Pract, 2009, 15(4): 353.
5Griesdale D E, de Souza R J, van Dam R M, et al. Intensive insulin therapy and mortality among critically ill patients: a meta- analysis including NICE - SUGAR study data [J]. CMAJ, 2009, 180(8): 821.
8Orford N R. Intensive insulin therapy in septic shock [ J ]. Crit Care Resusc, 2006, 8(3) : 230.
9Garber A J, Moghissi E S, Bransome E D, et al. American Collegeof Endocrinology position statement on inpatient dia- betes andmetabolie contro[J]. Endocr Pract, 2004, 10(1): 77.
10Ddlinger R P, Levy M M, Carlet J M, et al. Surviving sepsis cam - paign: international guidelines for management of severe sepsisand septic shock: 2008 [J]. Intensive Care Med, 2008, 34(1): 17.
